One step closer to improving melanoma diagnosis and prognosis with liquid biopsies

Ismael A Vergara^{1

2

3}, Mitchell S Stark⁴

Affiliations

¹ Melanoma Institute Australia.
² Faculty of Medicine and Health.
³ Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
⁴ Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD 4102, Australia.

Editorial

Ismael A Vergara et al. Br J Dermatol. 2023.

. 2023 Aug 24;189(3):255-259.

doi: 10.1093/bjd/ljad185.

Ismael A Vergara^{1

2

3}, Mitchell S Stark⁴

¹ Melanoma Institute Australia.
² Faculty of Medicine and Health.
³ Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
⁴ Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD 4102, Australia.

No abstract available

Conflict of interest statement

Conflicts of interest none to declare.

Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma.
Van Laar R, Latif B, King S, Love C, Taubenheim N, Kalansooriya E, Wang W, Saad M, Winship I, Azzi A, Lilleyman A, Landgren T. Van Laar R, et al. Br J Dermatol. 2023 Aug 24;189(3):292-301. doi: 10.1093/bjd/ljad137. Br J Dermatol. 2023. PMID: 37144735